Theratechnologies Provides Update on Sale Process

Core Viewpoint - Theratechnologies Inc. is evaluating the potential sale of the company following a proposal from Future Pak, with a special committee overseeing the process [1][2] Group 1: Company Overview - Theratechnologies is a commercial-stage biopharmaceutical company focused on innovative therapies that aim to redefine standards of care [3] Group 2: Board and Committee Actions - The Board of Directors has authorized a special committee of independent directors to oversee the evaluation of the potential sale [1] - The special committee has engaged multiple advisors, including Barclays, Fasken, Raymond James, and Norton Rose Fulbright, to assist in the process [1] Group 3: Ongoing Operations - Despite ongoing discussions regarding the potential sale, the company reassures stakeholders that operations will continue as normal [2]